TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money. June 27, 2008
TCL Archive St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project January 29, 2010